I’m honestly not sure. There are charitable and uncharitable interpretations. I started leaning more towards the latter once I read the IoM report, because it looks like the FDA flagrantly asked the IoM to write the bottom line first.
I’m honestly not sure. There are charitable and uncharitable interpretations. I started leaning more towards the latter once I read the IoM report, because it looks like the FDA flagrantly asked the IoM to write the bottom line first.